Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Cristhiam Rojas Hernandez MD

Cristhiam Mauricio Rojas Hernandez MD

Assistant Professor of Hematology, MD Anderson Cancer Center, Houston, Texas

Dr. Rojas Hernandez is an assistant professor of hematology at the MD Anderson Cancer Center in Houston. He received his medical degree from Universidad del Valle in Cali, Colombia. He completed residency training in internal medicine at Yale University School of Medicine (Bridgeport Hospital), and completed a clinical fellowship in hematology and oncology at the University of New Mexico Health Sciences Center in Albuquerque. 

Dr. Rojas Hernandez is actively engaged in research, and has published in numerous peer-reviewed journals. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, among other professional organizations.

Disclosures

Disclosures: Daichii Sankyo pharmaceutical for funding in clinical research related to the direct oral anticoagulants.

Recent Contributions to PracticeUpdate:

  1. The Burden of Immune-Mediated Refractoriness to Platelet Transfusions in MDS
  2. Apixaban for the Treatment of VTE Associated With Cancer
  3. The Epidemiology of Platelet Transfusions
  4. Prediction of Recurrent Venous Thrombosis in All Patients With a First Venous Thrombotic Event
  5. 2019 Top Stories in Benign Hematology: The Use of Inferior Vena Cava Devices in Trauma Scenarios: Da Vinci at Its Best
  6. Apixaban and Dalteparin in Active Malignancy-Associated VTE
  7. Expert Picks From ISTH 2019, Day 4: From Cristhiam Rojas Hernandez
  8. Expert Picks From ISTH 2019, Day 5: From Cristhiam Rojas Hernandez
  9. Expert Picks From ISTH 2019, Day 3: From Cristhiam Rojas Hernandez
  10. Expert Picks From ISTH 2019, Day 1: From Cristhiam Rojas Hernandez

Recently Updated